PBC is a chronic, progressive cholestatic liver disease of unknown origin. Some 50,000 people in the United States have the disease. At present, patients survive an average of 10 years after diagnosis.
Liver transplant is the only current treatment modality for end-stage patients.
It improves the survival rate of patients free of liver transplantation and improves liver biochemistry. Consulting Group Inc. All rights reserved. Please contact us with any comments, problems or bugs. Consulting Group Inc. All rights reserved.